We’re here to help

A child’s brain tumor diagnosis is overwhelming.

Resources for Families

No parent believes their child will be diagnosed with brain cancer.

When it happens, no patient, parent, sibling, or survivor should have to stand alone. The Pediatric Brain Tumor Foundation is there for families facing the most commonly diagnosed childhood cancer, responding with resources and community support that address every family member’s needs.

Our Impact

The Pediatric Brain Tumor Foundation is leading the way toward a future without childhood brain cancer. Every dollar we invest in research attracts an additional 12 dollars in follow-on funding.

Donate

Updates


Ride to End the Deadliest Childhood Disease: Pediatric Brain Tumor Foundation Kicks Off 2023 Ride for Kids Season at AIMExpo

Motorcycle dealers, manufacturers, and riders will get a first look at the Pediatric Brain Tumor Foundation’s plans for this year’s Ride for Kids at the 2023 AIMExpo Powersports Tradeshow taking place Feb. 15-17 in Las Vegas.  The Pediatric Brain Tumor Foundation is partnering with powersports industry brands and community events to create new opportunities throughout the year for the motorcycling community to help families. Riders can also choose to participate in one of the Pediatric Brain Tumor Foundation’s organized rides, ride and fundraise as a group, or hit the road, track or trail as an individual. On September 17, 2023, supporters will come together to celebrate this year’s impact at National Ride for Kids Day celebrations across the country.


Pediatric Brain Tumor Foundation Welcomes Leaders from Marsh McLennan Agency and Nestlé USA to Board of Directors

The Pediatric Brain Tumor Foundation, the largest patient advocacy funder of pediatric brain tumor research and leading champion for families and survivors, announces the appointment of Peter Krause, Chief Executive Officer and President, Marsh McLennan Agency (MMA) / Southeast, and Bryan Waddell, Brand Marketing Manager, Hot Pockets, Nestlé USA, to its Board of Directors.


Pediatric Brain Tumor Foundation Participates in Strategic Forum Addressing Targeted Drug Development for MAPK Pathway Inhibitor Treatments

The Pediatric Brain Tumor Foundation participated in a multi-disciplinary forum of researchers, pharmaceutical industry representatives, patient advocacy organizations, and regulatory agency representatives from the United States and Europe, as well as the publication of the forum's findings, to address the targeted drug development for MAPK Pathway inhibitor treatments.


See All